Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

This cross-sectional study investigates the association of dominant SARS-CoV-2 variants with COVID-19–related...

Rituximab, Lenalidomide, Acalabrutinib, Tafasitamab Alone and With Combination Chemotherapy for the Treatment of Newly Diagnosed Non-germinal Center Diffuse Large B-Cell Lymphoma, Smart Stop Study...

Objectives To quantify in absolute and relative terms how population-level COVID-19 death rates have changed in demographic and clinical subgroups. Design Retrospective cohort study...

  • 1554495319810908160 Profile photo of Madelyn

    Changes in COVID-19-related mortality across key demographic and clinical subgroups: an observational cohort study using the OpenSAFELY platform on 18m adults in England medRxiv. vaccination in the IS patients is blunted. Prophylaxis needed to save lives https://t.co/wtczkCgN1Y - view on twitter

Tixagevimab–cilgavimab for preventing COVID-19...

Tixagevimab plus cilgavimab, a SARS-CoV-2–neutralizing monoclonal antibody combination marketed as Evusheld, protected nonhospitalized individuals with mild to moderate COVID-19 symptoms from progressing to severe...

PURPOSE Outcomes are poor in TP53-mutant (mTP53) acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS), even after allogeneic hematopoietic stem-cell transplant (HCT). Eprenetapopt (APR-246)...

I rarely write about my personal experiences, but practising medicine during the covid pandemic has finally given me the motivation. I’m just one of...

Highly Divergent SARS-CoV-2 Alpha Variant in Chronically Infected Immunocompromised...

Background: Estimates of immunity and severity for the SARS-CoV-2 omicron subvariant BA.5 are important to assess the public health impact associated with...

Annual statistics on live births including countries of birth for non-UK-born mothers and...